How does high LDL increase my risk of heart attack or stroke?

High LDL cholesterol damages artery walls by forming plaques that narrow blood vessels and can rupture, blocking blood flow to the heart or brain. This process, called atherosclerosis, is the primary mechanism behind most heart attacks and strokes.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding LDL cholesterol and cardiovascular risk

Low-density lipoprotein (LDL) cholesterol, often called "bad cholesterol," plays a central role in the development of cardiovascular disease. When LDL levels remain elevated over time, they significantly increase your risk of experiencing a heart attack or stroke. Understanding this connection is crucial for taking proactive steps to protect your cardiovascular health.

The relationship between LDL and cardiovascular events isn't just statistical—it's a direct cause-and-effect relationship that occurs through specific biological mechanisms. Research shows that for every 39 mg/dL reduction in LDL cholesterol, there's approximately a 20-25% reduction in major cardiovascular events, including heart attacks and strokes.

How LDL cholesterol damages your arteries

The process begins when excess LDL particles in your bloodstream penetrate the inner lining of your artery walls, called the endothelium. Once inside the arterial wall, LDL particles undergo oxidation—a chemical change that makes them particularly harmful. This oxidized LDL triggers an inflammatory response, attracting white blood cells called macrophages to the area.

Warning Signs vs. Silent Progression of Atherosclerosis

StageWhat's HappeningSymptomsDetection Method
EarlyEarly (Years 0-20)Fatty streaks forming in arteriesNoneAdvanced lipid testing (ApoB, LDL-P)
IntermediateIntermediate (Years 20-40)Plaque growth, arterial narrowingUsually none, possible fatigueCoronary calcium scan, carotid ultrasound
AdvancedAdvanced (Years 40+)Significant narrowing, unstable plaquesChest pain, shortness of breathStress test, angiography
CriticalCritical EventPlaque rupture, clot formationHeart attack or strokeEmergency cardiac markers, imaging

Atherosclerosis often progresses without symptoms for decades, making regular biomarker testing essential for early detection.

These macrophages attempt to clear the oxidized LDL by engulfing it, but in doing so, they transform into foam cells. As foam cells accumulate, they form fatty streaks along the artery walls—the earliest visible sign of atherosclerosis. Over time, these fatty streaks develop into more complex structures called atherosclerotic plaques.

The formation of dangerous plaques

Atherosclerotic plaques consist of a lipid-rich core covered by a fibrous cap. As more LDL cholesterol accumulates, the plaque grows larger, gradually narrowing the artery and restricting blood flow. This narrowing alone can cause symptoms like chest pain (angina) or leg pain during exercise (claudication), depending on which arteries are affected.

However, the real danger lies in plaque instability. Plaques with large lipid cores and thin fibrous caps are particularly vulnerable to rupture. When a plaque ruptures, it exposes its contents to the bloodstream, triggering rapid blood clot formation at the site. This clot can completely block the artery, cutting off blood flow to vital organs.

The pathway to heart attacks

When plaque rupture and clot formation occur in the coronary arteries that supply blood to your heart muscle, the result is a heart attack (myocardial infarction). The severity depends on which artery is blocked and how much heart muscle is affected. Without prompt medical intervention to restore blood flow, the oxygen-starved heart muscle begins to die within minutes.

Even stable plaques that don't rupture can cause problems. As they grow larger, they can severely restrict blood flow to the heart, especially during physical activity or stress when the heart needs more oxygen. This can lead to chronic chest pain and reduced quality of life, eventually requiring procedures like angioplasty or bypass surgery.

Silent progression and sudden events

One of the most concerning aspects of high LDL is that atherosclerosis often progresses silently for years or decades before causing symptoms. Many people experience their first symptom as a major cardiac event. Studies show that up to 50% of heart attack victims had no prior warning signs, highlighting the importance of monitoring and managing LDL levels before problems arise.

How high LDL leads to strokes

The same atherosclerotic process that causes heart attacks can also lead to strokes when it affects the arteries supplying blood to the brain. The carotid arteries in the neck and the cerebral arteries within the brain are particularly vulnerable to plaque formation when LDL levels are elevated.

Ischemic strokes, which account for about 87% of all strokes, occur when a blood clot blocks an artery supplying the brain. This can happen through two main mechanisms: thrombotic strokes occur when a clot forms directly at the site of an atherosclerotic plaque in a brain artery, while embolic strokes happen when a clot or plaque fragment breaks off from another location (often the carotid arteries or heart) and travels to the brain.

The role of carotid artery disease

High LDL cholesterol frequently leads to plaque buildup in the carotid arteries, the major blood vessels in the neck that supply blood to the brain. As these plaques grow, they can significantly narrow the arteries, reducing blood flow to the brain. More dangerously, pieces of plaque can break off and travel to smaller brain arteries, causing blockages and strokes.

Regular monitoring of cardiovascular biomarkers, including advanced cholesterol panels, can help identify your risk before symptoms develop. Understanding your complete lipid profile provides crucial insights for preventing both heart attacks and strokes.

Risk factors that amplify LDL's danger

While high LDL alone significantly increases cardiovascular risk, certain factors can amplify its harmful effects. Understanding these interactions helps explain why some people with moderately elevated LDL experience cardiovascular events while others with higher levels don't.

  • High blood pressure: Hypertension damages artery walls, making them more susceptible to LDL infiltration and plaque formation
  • Diabetes: High blood sugar levels increase LDL oxidation and inflammation, accelerating atherosclerosis
  • Smoking: Tobacco use damages the endothelium and increases LDL oxidation while lowering protective HDL cholesterol
  • Chronic inflammation: Conditions causing systemic inflammation enhance the atherosclerotic process
  • Family history: Genetic factors can increase both LDL levels and susceptibility to its harmful effects
  • Age: Arterial damage accumulates over time, making older adults more vulnerable to LDL's effects

The metabolic syndrome connection

Metabolic syndrome—a cluster of conditions including abdominal obesity, high blood pressure, elevated blood sugar, and abnormal cholesterol levels—creates a particularly dangerous environment for LDL cholesterol. In this setting, LDL particles tend to be smaller and denser, making them more likely to penetrate artery walls and cause damage.

Beyond standard LDL: Advanced markers of risk

While standard LDL cholesterol measurement provides valuable information, advanced lipid testing offers deeper insights into cardiovascular risk. Apolipoprotein B (ApoB) measures the number of atherogenic particles in your blood, providing a more accurate assessment of risk than LDL cholesterol alone. Each LDL particle contains one ApoB protein, making it an excellent marker for particle count.

Research shows that ApoB is a better predictor of cardiovascular events than LDL cholesterol, especially in people with diabetes or metabolic syndrome. Additionally, the ratio of ApoB to ApoA1 (found in HDL particles) provides insight into the balance between harmful and protective cholesterol particles.

Particle size and cardiovascular risk

Not all LDL particles are equally dangerous. Small, dense LDL particles are more atherogenic than larger, buoyant ones. They penetrate artery walls more easily, are more prone to oxidation, and remain in circulation longer. People with a predominance of small, dense LDL particles have up to three times higher risk of heart disease, even with normal LDL cholesterol levels.

Taking action to lower your risk

Understanding how high LDL increases cardiovascular risk empowers you to take protective action. The good news is that lowering LDL cholesterol directly reduces your risk of heart attacks and strokes, with benefits appearing relatively quickly after levels improve.

Lifestyle modifications that work

  • Dietary changes: Reducing saturated fat intake, eliminating trans fats, and increasing soluble fiber can lower LDL by 10-20%
  • Regular exercise: Aerobic activity and resistance training improve lipid profiles and arterial health
  • Weight management: Losing excess weight, particularly abdominal fat, improves multiple cardiovascular risk factors
  • Stress reduction: Chronic stress contributes to inflammation and poor lifestyle choices that raise LDL
  • Smoking cessation: Quitting smoking improves endothelial function and reduces LDL oxidation

Medical interventions when needed

For many people, lifestyle changes alone aren't sufficient to achieve optimal LDL levels. Statin medications remain the first-line treatment, reducing LDL by 30-50% and significantly lowering cardiovascular event risk. Other options include ezetimibe, PCSK9 inhibitors, and bile acid sequestrants, often used in combination for maximum effect.

Regular monitoring through comprehensive cardiovascular testing helps track your progress and adjust treatment strategies. Advanced biomarker testing provides the detailed information needed to personalize your approach to cardiovascular risk reduction.

The importance of early detection and monitoring

Since atherosclerosis begins early in life and progresses silently, early detection and consistent monitoring are crucial. Studies show that even children and young adults can have fatty streaks in their arteries if LDL levels are elevated. The earlier you identify and address high LDL, the better your chances of preventing cardiovascular events.

Regular testing should include not just basic cholesterol panels but also advanced markers like ApoB, inflammatory markers such as high-sensitivity C-reactive protein (hs-CRP), and other metabolic indicators. This comprehensive approach provides a complete picture of your cardiovascular risk and helps guide targeted interventions.

Your path to cardiovascular protection

High LDL cholesterol increases your risk of heart attack and stroke through a well-understood process of arterial damage, plaque formation, and potential rupture. This isn't just a numbers game—it's about preventing the physical changes in your arteries that lead to life-threatening events. By understanding these mechanisms, monitoring your levels regularly, and taking appropriate action, you can significantly reduce your cardiovascular risk and protect your long-term health.

Remember that cardiovascular disease remains largely preventable through proper risk factor management. Whether through lifestyle modifications, medical treatment, or a combination of both, lowering your LDL cholesterol is one of the most powerful steps you can take to prevent heart attacks and strokes. The key is to start early, monitor regularly, and take consistent action based on your individual risk profile.

References

  1. Ference, B. A., et al. (2017). Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. European Heart Journal, 38(32), 2459-2472.[Link][PubMed][DOI]
  2. Sniderman, A. D., et al. (2019). Apolipoprotein B particles and cardiovascular disease: A narrative review. JAMA Cardiology, 4(12), 1287-1295.[PubMed][DOI]
  3. Libby, P. (2021). The changing landscape of atherosclerosis. Nature, 592(7855), 524-533.[Link][PubMed][DOI]

Frequently Asked Questions

How can I test my LDL cholesterol at home?

You can test your LDL cholesterol at home with SiPhox Health's Heart & Metabolic Program. This CLIA-certified program includes comprehensive cholesterol testing with LDL, HDL, triglycerides, and advanced markers like ApoB, providing lab-quality results from the comfort of your home.

What is considered a high LDL cholesterol level?

LDL cholesterol above 130 mg/dL is considered high, while 160-189 mg/dL is very high, and 190 mg/dL or above is extremely high. However, optimal levels for cardiovascular health are below 100 mg/dL, or below 70 mg/dL for those at high risk.

How quickly can I lower my LDL cholesterol?

With dietary changes and exercise, you may see LDL reductions of 10-20% within 6-8 weeks. Medications like statins can lower LDL by 30-50% within 4-6 weeks. Regular testing every 3-6 months helps track your progress.

Can I have a heart attack with normal LDL levels?

Yes, while high LDL is a major risk factor, heart attacks can occur with normal LDL levels due to other factors like inflammation, blood clotting disorders, or small dense LDL particles. This is why comprehensive testing including ApoB and inflammatory markers provides better risk assessment.

What's the difference between LDL cholesterol and ApoB testing?

LDL cholesterol measures the amount of cholesterol in LDL particles, while ApoB counts the actual number of atherogenic particles. Since each harmful particle contains one ApoB protein, ApoB testing provides a more accurate cardiovascular risk assessment, especially in people with diabetes or metabolic syndrome.

Related Articles

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details